Edgemoor Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$932K Hold
1,013
0.07% 99
2025
Q4
$1.09M Sell
1,013
-1,315
-56% -$1.26M 0.08% 93
2025
Q3
$1.78M Buy
2,328
+1,290
+124% +$960K 0.14% 82
2025
Q2
$810K Sell
1,038
-109
-10% -$84.7K 0.07% 101
2025
Q1
$948K Sell
1,147
-76
-6% -$63.2K 0.09% 98
2024
Q4
$944K Buy
1,223
+9
+0.7% +$7.45K 0.08% 96
2024
Q3
$1.08M Buy
1,214
+5
+0.4% +$4.5K 0.09% 93
2024
Q2
$1.09M Hold
1,209
0.1% 86
2024
Q1
$941K Buy
1,209
+16
+1% +$11.4K 0.09% 90
2023
Q4
$696K Sell
1,193
-135
-10% -$78.8K 0.07% 97
2023
Q3
$713K Hold
1,328
0.08% 96
2023
Q2
$623K Hold
1,328
0.07% 99
2023
Q1
$456K Sell
1,328
-718
-35% -$242K 0.06% 110
2022
Q4
$749K Buy
2,046
+550
+37% +$195K 0.09% 95
2022
Q3
$484K Buy
1,496
+77
+5% +$24.4K 0.06% 104
2022
Q2
$460K Buy
1,419
+8
+0.6% +$2.4K 0.06% 111
2022
Q1
$404K Buy
1,411
+289
+26% +$74.4K 0.04% 119
2021
Q4
$310K Sell
1,122
-6
-0.5% -$1.52K 0.03% 122
2021
Q3
$261K Hold
1,128
0.03% 117
2021
Q2
$259K Hold
1,128
0.02% 124
2021
Q1
$211K Buy
+1,128
New +$221K 0.02% 131
2016
Q1
Sell
-2,590
Closed -$218K 132
2015
Q4
$218K Hold
2,590
0.03% 129
2015
Q3
$217K Hold
2,590
0.03% 134
2015
Q2
$216K Buy
+2,590
New +$197K 0.03% 134
2015
Q1
Sell
-3,450
Closed -$238K 139
2014
Q4
$238K Hold
3,450
0.03% 127
2014
Q3
$224K Hold
3,450
0.03% 128
2014
Q2
$214K Buy
+3,450
New +$206K 0.03% 130

Other funds holding LLY

Edgemoor Investment Advisors's LLY Position: Q1 2026 in Review

Edgemoor Investment Advisors held its Eli Lilly (LLY) position steady in Q1 2026 at 1,013 shares worth $932K. The position accounts for 0.07% of the portfolio, ranked #99.

Edgemoor Investment Advisors first reported a position in LLY in Q2 2014 and has held it in 27 quarters since. The position peaked at $1.78M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Edgemoor Investment Advisors held 1,013 shares of Eli Lilly worth $932K as of Q1 2026.
  • Edgemoor Investment Advisors left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.07% of Edgemoor Investment Advisors's portfolio in Q1 2026, its #99 holding.
  • Edgemoor Investment Advisors first reported a position in Eli Lilly in Q2 2014 and has held it in 27 quarters since.
  • Edgemoor Investment Advisors's Eli Lilly position peaked at $1.78M in Q3 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Edgemoor Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.